Lifestyle modifications in the polycystic ovary syndrome: Role of physical exercise and importance of multidisciplinary approach;Modificações do estilo de vida na síndrome dos ovários policísticos: Papel do exercício físico e importância da abordagem multidisciplinar

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 5, 2008, Pages 261-267

  De Azevedo, George Dantas ^a   Costa, Eduardo Caldas ^a   Micussi, Maria Thereza Albuquerque Barbosa Cabral ^a   De Sá, Joceline Cássia Ferezni ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Cardiovascular diseases; Exercise; Food and nutrition education; Insulin resistance; Polycystic ovaries syndrome

Indexed keywords

CARDIOVASCULAR DISEASE; EXERCISE; FEMALE; FEMALE INFERTILITY; HUMAN; LIFESTYLE; OVARY POLYCYSTIC DISEASE; PATIENT CARE; REVIEW;

CARDIOVASCULAR DISEASES; EXERCISE; FEMALE; HUMANS; INFERTILITY, FEMALE; LIFE STYLE; PATIENT CARE TEAM; POLYCYSTIC OVARY SYNDROME;

EID: 51949111603     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685-97.
2. Kelly CJ, Connell JM, Cameron IT, Gould GW, Lyall H. The long term health consequences of polycystic ovary syndrome. BJOG. 2000;107(11):1327-38.
3. The Rotterdam ESHRE/ASRM-Sponsored. PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
4. Park KH, Kim JY, Ahn CW, Song YD, Lim SK, Lee HC. Polycystic ovarian syndrome (PCOS) and insulin resistance. Int J Gynaecol Obstet. 2001;74(3):261-7.
5. Cussons AJ, Stuckey BGA, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis. 2006;185(2):227-39.
6. Cibula D, Cífková F, Fanta M, Poledne R, Zivny J, Skibová J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod. 2000;15(4):785-9.
7. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103(10):1410-5.
8. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG. 2006;113(10):1203-9.
9. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453-5.
10. Orio F, Giallauria F, Palomba S, Cascella T, Manguso F, Vuolo L, et al. Cardiopulmonary impairment in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(8):2967-71.
11. Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhão TM. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008;89(3):649-55.
12. Azevedo GD, Duarte JM, Souza MO, Costa-E-Silva TD, Soares EM, Maranhão TM. Irregularidade do ciclo menstrual no menacme como marcador para fatores de risco cardiovasculares na pós-menopausa. Arq Bras Endocrinol Metabol. 2006;50(5):876-83.
13. Soares EMM, Soares GM, Silva Filho JG, Melo MCL, Azevedo GD, Maranhão TMO. Causas de óbitos femininos no Rio Grande do Norte (RN) em 2002 e 2003 [videocassete]. In: Anais do 51° Congresso Brasileiro de Ginecologia e Obstetrícia; 2005 nov 22-26; Rio de Janeiro, Brasil. Rio de Janeiro: TV MED; 2005.
14. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril. 2004;82(2):421-9.
15. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab. 2002;13(6):251-7.
16. Moran L, Brinkworth G, Noakes M, Norman RJ. Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online. 2006;12(5):569-78.
17. Bruner B, Chad K, Chizen D. Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Appl Physiol Nutr Metab. 2006;31(4):384-91.
18. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84(4):1470-4.
19. Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(4):1379-84.
20. Orio F, Giallauria F, Palomba S, Manguso F, Orio M, Tafuri D, et al. Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women. Clin Endocrinol (Oxf). 2008;68(6):976-81.
21. Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, et al. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod. 2008;23(3):642-50.
22. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf). 2005;62(3):289-95.
23. Randeva HS, Lewandowski KC, Drzewoski J, Brooke-Wavell K, O'Callaghan C, Czupryniak L, et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(10): 4496-501.
24. Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008;23(1):153-9.
25. Yarali H, Yildirir A, Aybar F, Kabakçi G, Bükülmez O, Akgül E, et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76(3):511-6.
26. Boushey CJ, Beresford SA, Omenn GS, Motulsky KG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274(13):1049-57.
27. Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger Jr RS, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA. 1995;273(14):1093-8.
28. Erikssen G, Liestøl K, Bjørnholt J, Thaulow E, Sandvik L, Erikssen J. Changes in physical fitness and changes in mortality. Lancet. 1998;352(9130):759-62.
29. Lamonte MJ, Eisenman PA, Adams TD, Shults BB, Ainsworth BE, Yanowitz FG. Cardiorespiratory fitness and coronary heart disease risk factors: the LDS Hospital Fitness Institute Cohort. Circulation. 2000;102(14):1623-8.
30. Laukkanen JA, Lakka TA, Rauramaa R, Kuhanen R, Venalainen JM, Salonen R, et al. Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med. 2001;161(6):825-31.
31. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al. Prediction of long-term prognosis in 12.169 men referred for cardiac rehabilitation. Circulation. 2002;106(6): 666-71.
32. Seibaek M, Vestergaard H, Burchardt H, Sloth C, Torp-Pedersen C, Nielsen SL, et al. Insulin resistance and maximal oxygen uptake. Clin Cardiol. 2003;26(11):515-20.
33. Sirikul B, Gower BA, Hunter GR, Larson-Meyer DE, Newcomer BR. Relationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle. Am J Physiol Endocrinol Metab. 2006;291(4):E724-8.